U.S. Residential REITs Stock News

NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

Assessing Applied Materials (AMAT) After A 108% One Year Share Price Surge

If you are wondering whether Applied Materials' share price still reflects good value after its strong run, it helps to step back and look at what the current market price might be implying about the business. The stock last closed at US$354.91, with returns of 7.9% over 7 days, 8.5% over 30 days, 32.0% year to date, and 108.4% over the past year, which naturally raises questions about how much of the story is already priced in and how risk is being perceived. Recent attention around Applied...
NYSE:DLB
NYSE:DLBSoftware

Assessing Dolby Laboratories (DLB) Valuation After Recent Share Price Weakness

Dolby Laboratories (DLB) has drawn investor attention after a period where the share price shows mixed returns, with gains over the past month and past 3 months, but weaker performance over the past year. See our latest analysis for Dolby Laboratories. At a share price of US$66.02, Dolby’s short term momentum has softened, with a 7 day share price return of a 3.18% decline, while the 1 year total shareholder return of a 20.32% decline points to sentiment that has cooled over a longer...
NYSE:RIG
NYSE:RIGEnergy Services

A Look At Transocean (RIG) Valuation After Recent Share Price Surge And Conflicting Fair Value Estimates

Transocean (RIG) has drawn attention after a sharp recent move in its share price, with returns of 8.46% over the past day and 20.22% over the past week, catching investor interest. See our latest analysis for Transocean. That sharp move comes on top of strong recent momentum, with a 30 day share price return of 54.61% and a year to date share price return of 54.25%, while the 1 year total shareholder return stands at 84.23% and the 3 year total shareholder return is negative. This means...
NYSE:UE
NYSE:UERetail REITs

Urban Edge Dividend Hike Raises Questions On Earnings And Coverage Risks

Urban Edge Properties (NYSE:UE) announced an 11% increase to its annual dividend. The higher dividend was approved by the board as part of its latest capital return decision. For investors watching NYSE:UE, the dividend hike comes with the shares trading around $20.77. The stock has logged a 9.5% return over the past 30 days and an 8.7% return year to date, with a 52.3% return over three years and 47.7% over five years. This mix of recent and multiyear performance provides useful context...
NasdaqGS:PAX
NasdaqGS:PAXCapital Markets

Patria Expands Platform With New Acquisitions And Latin America Credit Push

Patria Investments (NasdaqGS:PAX) has agreed to acquire majority stakes in Brazil based Solis Investimentos, Share Student Living, and WP Global Partners. The transactions expand Patria's reach in structured credit, student housing, and North American middle market investment solutions. Alongside these acquisitions, Patria is launching a new private credit strategy focused on Latin America. Patria Investments, a Latin America focused alternative asset manager listed as NasdaqGS:PAX, is...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Assessing Legend Biotech (LEGN) Valuation After FDA Draft Guidance Favors CARTITUDE 6 Trial Design

Recent FDA draft guidance supporting Minimal Residual Disease negativity and complete response rate as expedited approval endpoints in multiple myeloma has put fresh attention on Legend Biotech (LEGN) and its CARTITUDE-6 trial design. See our latest analysis for Legend Biotech. Despite the positive regulatory backdrop and the recent appointment of Gareth Kung to the board and as Audit Committee chair, Legend Biotech’s shares have been under pressure, with a 30 day share price return of a...
NYSE:APD
NYSE:APDChemicals

A Look At Air Products And Chemicals (APD) Valuation After Q1 2026 EPS Beat And Margin Improvement

Conference spotlight after stronger Q1 results Air Products and Chemicals (APD) heads into its Barclays Industrial Select Conference appearance on February 17 with fresh attention from investors after fiscal Q1 2026 adjusted EPS exceeded both Wall Street expectations and company guidance. See our latest analysis for Air Products and Chemicals. Even with the Q1 earnings surprise and a 6.4% share price jump on January 30, recent news around director share sales and dividend funding concerns has...
NYSE:RNST
NYSE:RNSTBanks

Should Renasant’s Earnings Beat and Integration Progress Prompt a Fresh Look From RNST Investors?

In the most recent quarter, Renasant reported revenue of US$282 million, exceeding analyst expectations and delivering stronger profitability and improved efficiency, while an executive advisor sold 20,000 shares in a past insider transaction. The quarter also highlighted successful integration of The First Bancshares, reinforcing how scale and efficiency gains are becoming increasingly important to Renasant’s business model. With Renasant’s earnings beating expectations and integration...
NYSE:EVR
NYSE:EVRCapital Markets

Does Evercore’s (EVR) Strong 2025 Results And New Director Hint At A Shifting Risk Profile?

Evercore Inc. reported past fourth-quarter 2025 revenue of US$1,297.03 million and net income of US$203.95 million, with full-year 2025 revenue of US$3.88 billion and net income of US$591.92 million, alongside a declared US$0.84 dividend, completion of a share repurchase tranche, and the appointment of Christine Varney to its Board effective March 1, 2026. Christine Varney’s extensive antitrust and regulatory background, including senior roles at the DOJ and FTC, adds governance and risk...
NYSE:EQBK
NYSE:EQBKBanks

Insider-Owned Growth Companies That Could Transform Your Portfolio

As the U.S. stock market kicks off February with a strong performance, highlighted by significant gains in major indices like the Dow Jones and S&P 500, investors are keenly observing how economic policies and international trade developments might influence future trends. In this dynamic environment, companies with high insider ownership often draw attention for their potential to align management interests with shareholder value, making them intriguing candidates for those looking to...
OTCPK:RDGL
OTCPK:RDGLMedical Equipment

Gaia Leads The Charge With 2 Other Promising Penny Stocks

The U.S. stock market kicked off February with a strong performance, as major indexes like the Dow Jones and S&P 500 saw significant gains. Amidst this backdrop of market optimism, investors are increasingly exploring opportunities beyond the well-known giants. Penny stocks, though often considered niche investments, continue to capture interest due to their potential for growth in smaller or newer companies. While the term may seem outdated, these stocks can still present compelling...
NasdaqCM:VFF
NasdaqCM:VFFFood

Exploring 3 Undiscovered Gems In The US Market

As the U.S. stock market kicks off February with a notable upswing, highlighted by the Dow's impressive 515-point gain and the S&P 500 nearing record highs, investors are keenly observing how economic indicators like factory activity expansion might influence small-cap stocks. In this dynamic environment, identifying promising yet overlooked opportunities can be crucial for portfolio diversification and potential growth. Exploring lesser-known stocks that align with current economic trends...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

10x Genomics (TXG) Is Down 5.4% After Shelf Offer Filing And Cautious 2026 Outlook What's Changed

In February 2026, 10x Genomics reported fourth-quarter 2025 revenue of US$166.03 million with a reduced net loss of US$16.25 million, and filed a US$138.83 million shelf registration for 7,661,479 Class A shares tied to an employee stock plan. Alongside improved full-year 2025 loss metrics and cautious 2026 revenue guidance, 10x Genomics deepened its role in AI-driven cancer research through the PharosAI collaboration using its Xenium spatial platform. Next, we’ll assess how stronger cost...
NYSE:AAP
NYSE:AAPSpecialty Retail

Does Advance Auto Parts’ Profit Rebound and 2026 Outlook Change The Bull Case For AAP?

Advance Auto Parts recently reported fourth-quarter 2025 results showing US$1,973 million in sales and a return to profitability with US$6 million in net income, alongside improved margins and positive comparable sales growth. The company paired this earnings recovery with 2026 guidance for US$8,485 million to US$8,575 million in net sales and affirmed a regular US$0.25 per-share dividend, underscoring its ongoing turnaround and capital-return plans. We’ll now examine how this earnings...
NasdaqGS:ACLX
NasdaqGS:ACLXBiotechs

Did Anito-cel’s D-Domain Safety Signal at Tandem Just Shift Arcellx's (ACLX) Investment Narrative?

Arcellx announced that a late-breaking abstract on its BCMA-directed CAR T therapy anitocabtagene autoleucel (anito-cel), featuring its novel D-Domain binder, was accepted and presented at the 2026 Tandem Meetings, highlighting preclinical data in relapsed or refractory multiple myeloma. The preclinical poster suggested that the compact D-Domain binder avoided tonic signaling and off-target activity seen with some other BCMA CAR constructs, potentially pointing to a differentiated safety...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Is Nutanix (NTNX) Priced Attractive After Recent Share Price Weakness

If you are wondering whether Nutanix at around US$41.76 is a bargain or a value trap, you are not alone. This article is here to walk you through what the current price might be telling you. The stock has had a mixed run, with a 0.3% decline over the last week, an 8.7% decline over the past month, a 17.5% decline year to date, but returns of 50.1% over 3 years and 30.6% over 5 years that may still catch the eye of longer term investors. Recent coverage has focused on Nutanix as a key player...
NYSE:GE
NYSE:GEAerospace & Defense

Has General Electric (GE) Run Too Far After Its 51% One Year Rally

If you are wondering whether General Electric's share price still makes sense after a strong run, this article is here to help you unpack what that price might be implying about value today. GE closed at US$315.41, with returns of 51.0% over 1 year and a very large gain over 3 years, while the last 7 days, 30 days and year to date show modest pullbacks of 0.3%, 3.0% and 1.7% respectively. Recent news around General Electric has mainly focused on its ongoing position in the capital goods...
NYSE:THR
NYSE:THRElectrical

Does Thermon (THR) Prioritize Deals Over Buybacks as Liquidity Rises and Repurchases Pause?

In early February 2026, Thermon Group Holdings reported third-quarter and nine-month results showing higher sales and slightly improved earnings per share year on year, while highlighting US$141 million in total cash and available liquidity to support growth initiatives. An interesting wrinkle is that Thermon completed a US$36.19 million share repurchase program by March 2024 yet bought back no shares in the most recent quarter, suggesting current capital is being preserved for potential...
NasdaqGM:TNGX
NasdaqGM:TNGXBiotechs

Pivotal Vopimetostat Pancreatic Cancer Trial Plan Might Change The Case For Investing In Tango Therapeutics (TNGX)

Tango Therapeutics, Inc. recently presented at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 in New York, where President and CEO Malte Peters outlined plans to advance vopimetostat into a pivotal 300-patient randomized trial in second-line pancreatic cancer following supportive FDA interactions. The company also highlighted preclinical synergy between vopimetostat and Revolution Medicines’ RAS inhibitors, alongside early progress for CNS agent TNG456, signaling a broader...
NYSE:WAB
NYSE:WABMachinery

A Look At Wabtec (WAB) Valuation After New Locomotive Deals And Higher Buyback Authorization

Westinghouse Air Brake Technologies (WAB) is back in focus after securing multihundred-million-dollar locomotive deals with Union Pacific and CSX, updating its 2026 sales guidance and expanding its remaining share repurchase authorization. See our latest analysis for Westinghouse Air Brake Technologies. The recent Union Pacific and CSX locomotive agreements, updated 2026 sales guidance in the US$12.19b to US$12.49b range, stepped-up buybacks and a dividend increase come as the share price has...
NYSE:GDDY
NYSE:GDDYIT

Assessing GoDaddy (GDDY) After A 51% Slide And Contrasting Valuation Signals

If you are wondering whether GoDaddy's current share price reflects its true worth, this article will walk you through what the market is pricing in and how that compares with a range of valuation checks. The stock closed at US$89.12, with a 7.3% decline over the last 7 days, a 14.7% decline over the last 30 days, a 24.8% decline year to date, and a 50.8% decline over the past year, while still showing 16.9% and 9.1% returns over the last 3 and 5 years respectively. Recent coverage has...
NYSE:RBC
NYSE:RBCMachinery

RBC Bearings Leans On Long Cycle Aerospace And Defense Growth

Wasatch Global Investors recently highlighted RBC Bearings (NYSE:RBC) as a core holding, citing continued strong execution and a positive outlook. Company management pointed to robust aerospace and defense demand, with strength from submarine, missile, and aircraft programs. RBC Bearings also reported an increased share of business with Airbus, indicating deeper involvement in commercial aerospace platforms. RBC Bearings, a supplier of engineered bearings and components, sits at the...
NYSE:SLGN
NYSE:SLGNPackaging

Assessing Silgan Holdings (SLGN) Valuation After Recent Share Price Momentum

With no single headline event driving the move, Silgan Holdings (SLGN) has drawn attention after a month and past 3 months of positive share performance, prompting investors to reassess its packaging-focused business. See our latest analysis for Silgan Holdings. The recent 30-day share price return of 13.51% and 90-day share price return of 27.93% contrast with a 1-year total shareholder return decline of 8.65%. This suggests momentum in the share price while longer term holders have had a...